Amenorrhea: Clinical Trials

63 trials for Amenorrhea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 11 unknown, 5 recruiting, 5 withdrawn. 15 Not applicable, 14 Phase 2, 7 Phase 3, 6 Phase 1, 5 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable15Completed 8, Unknown 4, Not yet recruiting 2, Withdrawn 1
Phase 214Completed 9, Recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1
Phase 37Completed 2, Unknown 2, Withdrawn 2, Recruiting 1
Phase 16Terminated 2, Withdrawn 2, Completed 1, Unknown 1
Phase 45Completed 2, Unknown 2, Terminated 1

Follow Amenorrhea: new trials by email Literature Review of Amenorrhea trials Research Report on Amenorrhea

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Resistance Training on Women With Functional Hypothalamic Amenorrhea
Resistance Training Program - Amenorrhea, Functional Hypothalamic Amenorrhea (FHA)
Not applicableNot yet recruitingCatholic University of Murcia282026-05-152026-05-29
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Mibavademab, Placebo - Functional Hypothalamic Amenorrhea, FHA
Phase 2RecruitingRegeneron Pharmaceuticals342026-03-112026-10-01
Health and Lifestyle Support for Functional Hypothalamic Amenorrhea
Psychoeducaction or treatment as usual, Treatment as usual (TAU) - Hypothalamic Amenorrhea, Functional
Not applicableNot yet recruitingKarolinska Institutet702026-02-012026-02-04
A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump
Lutrepulse - Amenorrhea, Fertility
Phase 1WithdrawnFerring Pharmaceuticals2025-09-122025-11-14
Myo-Inositol and D-Chiro-Inositol for Menstrual Irregularities and Hormone Changes in Women With Polycystic Ovarian Syndrome
Myo-Inositol and D-Chiro-Inositol Combination Therapy, placebo (folic acid) - Polycystic Ovary Syndrome (PCOS), Myo-inositol
Phase 4CompletedNishtar Medical University602025-06-012026-07-14
Evaluation of Bone Mineral Density Indications and Outcomes in Female Adolescents: Implications for Early Detection of Osteopenia/Osteoporosis and Gynecologic Practice
Bone Density, Osteopenia
CompletedBagcilar Training and Research Hospital742025-06-012025-09-15
Treatment of Menstrual Cycle Alterations in Adolescents
myo-Inositol plus DIoscorea Villosa - Amenorrhea, Oligomenorrhea
Not applicableCompletedLo.Li.Pharma s.r.l412025-06-012026-10-09
Observation of Environment and Reproductive-Endocrine Effects
Hypogonadism, Hypergonadism
RecruitingNational Institute of Environmental Health Sciences (NIEHS)3002024-07-012026-09-28
Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health (ARCH)
Hypothalamic Amenorrhea
Active not recruitingMayo Clinic902023-01-172026-06-04
Compliance and Endometriosis
Compliance with medical treatment for endometriosis - Endometriosis
CompletedHospices Civils de Lyon582022-11-172024-05-20
Isolated Growth Hormone Deficiency and Amennorrhea
Hormone panel tests - Growth Hormone Deficiency
CompletedUniversitas Padjadjaran12021-12-012022-07-08
Hormonal Status, Performance and Health in Elite Female Athlete
Multidisciplinary monitoring of healthy women - Healthy
Not applicableUnknownUniversité Paris-Saclay-Assistance publique des hôpitaux de Paris802021-09-152021-08-31
Psychological Impact of Amenorrhea in Women With Endometriosis
Estroprogestinic therapy (Etinil-estradiol/levonorgestre), Gonadotropin-releasing hormone agonist (Leuprorelin acetate), Add back therapy 1 (tibolone) - Amenorrhea, Endometriosis
Phase 4UnknownUniversity of Cagliari502021-06-012021-02-04
The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
Yasmin, Diane-35 - Polycystic Ovary Syndrome
Not applicableUnknownInonu University422021-03-012022-05-19
Retrospective Observational Evaluation of the Bone Mineral Density Outcome in Young Women With Amenorrhea
Amenorrhea
RecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna1802020-11-092025-06-11
Ovarian Morphology in Girls
Amenorrhea, Oligomenorrhea
UnknownCornell University602020-01-312024-08-12
Mental Health in Fitness Instructors
Mental Health Wellness 1, Depression, Anxiety
CompletedNorwegian School of Sport Sciences3042019-11-012020-06-12
The Role of Estrogen in the Neurobiology of Eating Disorders
17-β estradiol transdermal patches with cyclic progesterone, Placebo patch and pill - Eating Disorders, Hypoestrogenemia
Phase 2Active not recruitingMassachusetts General Hospital1202019-06-132026-05-29
Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women
Autologous PRP intra ovarian infusion, Autologous PFP intra ovarian infusion - Infertility, Female, Anovulatory Infertility
Phase 2 / Phase 3RecruitingGenesis Athens Clinic1002019-05-212026-07-08
Reproductive Health Outcomes by Method of Breast Milk Feeding
Breast Feeding, Milk Expression, Breast
CompletedUniversity of California, Davis3942018-06-272021-08-18

Showing 20 of 63. Sign in to see all of them.

Narrower conditions

Infertility (10)  ·  Polycystic Ovary Syndrome (10)  ·  Oligomenorrhea (7)  ·  Hypogonadism (6)  ·  Bone Diseases, Metabolic (5)  ·  Anorexia Nervosa (4)  ·  Anovulation (4)  ·  Hirsutism (4)  ·  Kallmann Syndrome (4)  ·  Menstruation Disturbances (4)  ·  Motor Activity (4)  ·  Primary Ovarian Insufficiency (4)  ·  Breast Neoplasms (3)  ·  Endocrine System Diseases (3)

Broader conditions

Pathologic Processes (63)  ·  Pathological Conditions, Signs and Symptoms (63)  ·  Menstruation Disturbances (59)  ·  Urogenital Diseases (27)  ·  Female Urogenital Diseases (26)  ·  Female Urogenital Diseases and Pregnancy Complications (26)  ·  Genital Diseases (25)  ·  Gonadal Disorders (22)  ·  Genital Diseases, Female (21)  ·  Endocrine System Diseases (20)  ·  Adnexal Diseases (16)  ·  Ovarian Diseases (16)  ·  Signs and Symptoms (14)  ·  Neoplasms (13)  ·  Cysts (10)

Interventions

Progesterone (5)  ·  Estradiol (3)  ·  Gonadotropin-Releasing Hormone (3)  ·  Levonorgestrel (3)  ·  Metformin (3)  ·  Cyproterone acetate, ethinyl estradiol drug combination (2)  ·  Estrogens, Conjugated (USP) (2)  ·  Inositol (2)  ·  Leuprolide (2)  ·  Musculoskeletal Manipulations (2)  ·  Surveys and Questionnaires (2)  ·  asoprisnil (2)  ·  telapristone acetate (2)  ·  Calcium Carbonate (1)  ·  Cholecalciferol (1)

Sponsors

Massachusetts General Hospital (7)  ·  National Institute of Environmental Health Sciences (NIEHS) (4)  ·  Cornell University (3)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3)  ·  Abbott (2)  ·  Bayer (2)  ·  Central South University (2)  ·  Columbia University (2)  ·  Duramed Research (2)  ·  Penn State University (2)  ·  Repros Therapeutics Inc. (2)  ·  University of Nottingham (2)  ·  Bagcilar Training and Research Hospital (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Catholic University of Murcia (1)

Countries

United States (36)  ·  China (3)  ·  Germany (2)  ·  Italy (2)  ·  Norway (2)  ·  Spain (2)  ·  Sweden (2)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)  ·  Algeria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)  ·  Georgia (1)

Top investigators

Natalie D Shaw, M.D. (3)  ·  Chrisandra Shufelt, MD (2)  ·  Dawn-Marie Walker, PhD (2)  ·  Janet E Hall, M.D. (2)  ·  Agni Pantou, MD (1)  ·  Andre van As, M.D., Ph.D (1)  ·  Angela Guarda, MD (1)  ·  Anne A Klibanski, MD (1)  ·  Anne B Loucks, Ph.D. (1)  ·  Aviva B Sopher, MD, MS, MS (1)  ·  Aviva Sopher, MD, MS, MS (1)  ·  Ayman Al-Hendy, MD, PhD (1)  ·  Bernhard Uehleke, Dr.med. Dr.rer.nat. (PhD) (1)

Results publications

PMID 32034419, PMID 36708012, PMID 38335228, PMID 21464293, PMID 21593494, PMID 21660636, PMID 21698665, PMID 21741057, PMID 21816790, PMID 22252944, PMID 22282904, PMID 22341881, PMID 22728230, PMID 23341491, PMID 23382191, PMID 24021517, PMID 24703486, PMID 25003376, PMID 25148234, PMID 25352438, PMID 28297591, PMID 29023359, PMID 30301734, PMID 30476179, PMID 30639922, PMID 30896746, PMID 31603998, PMID 32480405, PMID 32680541, PMID 32870266, PMID 33045195, PMID 33051459, PMID 33651630, PMID 34164675, PMID 34528857, PMID 35170727, PMID 36400597, PMID 36947969, PMID 37610989, PMID 38421421, PMID 39097160, PMID 40279653, PMID 40294815, PMID 40929646, PMID 41099383, PMID 41121582, PMID 41868592

NIH funding

2023 (1), M01RR000034 (1), M01RR001032 (1), R01DK062249 (1), R01HD039245 (1), R01HD060827 (1), R01HD093748 (1), R01HD106096 (1), R34HD048526 (1), R56HD089962 (1), U54HD028138 (1)